论文部分内容阅读
宫颈癌在女性恶性肿瘤中的发生率仅次于乳腺癌,位居女性恶性肿瘤的第二位。从宫颈上皮内瘤变(CIN)到宫颈癌的演变一般8-10年,CIN治愈率可达100%[1]。有效的宫颈筛查能够使宫颈癌死亡率明显下降。宫颈薄层液基细胞学筛查(TCT)目前是检测宫颈癌及癌前病变的主要方法,在发达国家已有十几年的历史,有性生活的女性每年或每2年进行宫颈癌筛查。根据最新美国宫颈癌筛查指南,有性生活的女性每3年进行宫颈癌筛查,进而使其
The incidence of cervical cancer in women with malignant tumors is second only to that of breast cancer, ranking the second among women with malignant tumors. From cervical intraepithelial neoplasia (CIN) to the evolution of cervical cancer generally 8-10 years, CIN cure rate of up to 100% [1]. Effective cervical screening can significantly reduce the mortality rate of cervical cancer. Cervical thin liquid-based cytological screening (TCT) is currently the detection of cervical cancer and precancerous lesions of the main methods in developed countries have more than 10 years of history, women with sex life every year or every 2 years cervical cancer screening check. According to the latest guide to screening for cervical cancer in the United States, women with sex life undergo cervical cancer screening every 3 years,